It is elusive whether the insulin-related metabolic changes observed in these PD models are associated with the damage solely in the nigrostriatal or/and in other brain regions, and secondly, whether they are the consequence of direct toxic effects or are induced indirectly by a lack of dopamine signalling. This evidence concerns the gene INS and Parkinson disease.